Dusseldorf - Delayed Quote EUR
Seres Therapeutics Inc (1S9.DU)
0.0000
0.0000
(0.00%)
At close: April 17 at 7:30:21 PM GMT+2
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-148,609
-148,609
-117,354
-228,816
6,688
Investing Cash Flow
142,293
142,293
10,582
82,428
64,088
Financing Cash Flow
-90,372
-90,372
71,705
129,602
1,178
End Cash Position
39,461
39,461
136,150
171,215
188,002
Interest Paid Supplemental Data
10,858
10,858
12,547
4,926
2,446
Capital Expenditure
-380
-380
-7,975
-9,821
-9,566
Issuance of Capital Stock
23,530
23,530
18,159
101,168
--
Issuance of Debt
--
--
103,378
27,606
--
Repayment of Debt
-127,905
-127,905
-52,860
-1,907
-948
Free Cash Flow
-148,989
-148,989
-125,329
-238,637
-2,878
12/31/2021 - 4/17/2024
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade